Raymond James & Associates’s Concentrix CNXC Stock Holding History
Bought
Maintained
Sold
Other funds holding CNXC
GBL
IC
Raymond James & Associates's CNXC Position: Q3 2024 in Review
Raymond James & Associates increased its Concentrix (CNXC) stake by 73% in Q3 2024, buying an estimated $1.57M and bringing the position to 55,313 shares worth $2.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2008.
Raymond James & Associates first reported a position in CNXC in Q4 2020 and has held it in 16 quarters since. The position peaked at $10.1M in Q1 2021. 284 funds tracked by Wall St. Rank hold CNXC as of Q3 2024.
- Raymond James & Associates held 55,313 shares of Concentrix worth $2.83M as of Q3 2024.
- Raymond James & Associates bought 23,387 Concentrix shares in Q3 2024, an estimated $1.57M.
- Concentrix made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2008 holding.
- Raymond James & Associates first reported a position in Concentrix in Q4 2020 and has held it in 16 quarters since.
- Raymond James & Associates's Concentrix position peaked at $10.1M in Q1 2021.
- 284 funds tracked by Wall St. Rank held Concentrix as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.